338 related articles for article (PubMed ID: 29047105)
1. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
[TBL] [Abstract][Full Text] [Related]
2. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma.
Mao L; Fan TF; Wu L; Yu GT; Deng WW; Chen L; Bu LL; Ma SR; Liu B; Bian Y; Kulkarni AB; Zhang WF; Sun ZJ
J Cell Mol Med; 2017 Sep; 21(9):2199-2210. PubMed ID: 28401653
[TBL] [Abstract][Full Text] [Related]
4. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer.
Liu JF; Wu L; Yang LL; Deng WW; Mao L; Wu H; Zhang WF; Sun ZJ
J Exp Clin Cancer Res; 2018 Mar; 37(1):44. PubMed ID: 29506555
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma.
Yu GT; Mao L; Wu L; Deng WW; Bu LL; Liu JF; Chen L; Yang LL; Wu H; Zhang WF; Sun ZJ
Cell Mol Life Sci; 2018 Nov; 75(22):4223-4234. PubMed ID: 29955905
[TBL] [Abstract][Full Text] [Related]
6. PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma.
Yu GT; Bu LL; Huang CF; Zhang WF; Chen WJ; Gutkind JS; Kulkarni AB; Sun ZJ
Oncotarget; 2015 Dec; 6(39):42067-80. PubMed ID: 26573233
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
[TBL] [Abstract][Full Text] [Related]
8. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
[TBL] [Abstract][Full Text] [Related]
9. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
Younis RH; Han KL; Webb TJ
J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
[TBL] [Abstract][Full Text] [Related]
10. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
Weed DT; Vella JL; Reis IM; De la Fuente AC; Gomez C; Sargi Z; Nazarian R; Califano J; Borrello I; Serafini P
Clin Cancer Res; 2015 Jan; 21(1):39-48. PubMed ID: 25320361
[TBL] [Abstract][Full Text] [Related]
11. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
Chen L; Huang CF; Li YC; Deng WW; Mao L; Wu L; Zhang WF; Zhang L; Sun ZJ
Cell Mol Life Sci; 2018 Jun; 75(11):2045-2058. PubMed ID: 29184980
[TBL] [Abstract][Full Text] [Related]
12. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.
Zhao ZL; Zhang L; Huang CF; Ma SR; Bu LL; Liu JF; Yu GT; Liu B; Gutkind JS; Kulkarni AB; Zhang WF; Sun ZJ
Sci Rep; 2016 Apr; 6():24704. PubMed ID: 27108536
[TBL] [Abstract][Full Text] [Related]
13. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.
Hall B; Nakashima H; Sun ZJ; Sato Y; Bian Y; Husain SR; Puri RK; Kulkarni AB
J Transl Med; 2013 Feb; 11():45. PubMed ID: 23421960
[TBL] [Abstract][Full Text] [Related]
14. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
15. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ
Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.
Sun ZJ; Zhang L; Hall B; Bian Y; Gutkind JS; Kulkarni AB
Clin Cancer Res; 2012 Oct; 18(19):5304-13. PubMed ID: 22859719
[TBL] [Abstract][Full Text] [Related]
19. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
20. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]